Sign In
Buy IDXX
$545.73
-16.36 (-2.91%)
At Close: Jun 22, 2026
IDEXX Laboratories Inc (IDXX) Stock Down 4.7% -- Now Undervalued? GF Score: 96/100
06:11pm, Wednesday, 17'th Jun 2026
On June 17, 2026, IDEXX Laboratories Inc (IDXX) shares fell 4.7% to $546.09. The stock's current price is within a 52-week range of $506.91 to $769.98, reflecti
Here's Why Idexx Laboratories (IDXX) is a Strong Momentum Stock
10:52am, Thursday, 11'th Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock
10:46am, Tuesday, 09'th Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Idexx (IDXX) Down 3.2% Since Last Earnings Report: Can It Rebound?
12:36pm, Thursday, 04'th Jun 2026
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference
07:02am, Saturday, 30'th May 2026
IDEXX Laboratories NASDAQ: IDXX President and CEO Michael Erickson used a Stifel investor conference appearance to emphasize the company's innovation pipeline, expanding commercial reach and growing u
IDEXX Laboratories, Inc. (IDXX) Presents at Stifel Jaws & Paws Conference 2026 Transcript
01:27pm, Wednesday, 27'th May 2026
IDEXX Laboratories, Inc. (IDXX) Presents at Stifel Jaws & Paws Conference 2026 Transcript
IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection
07:00am, Tuesday, 26'th May 2026
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX expands Fecal Dx™ antigen testing with taeniid tapeworm detection for broader intestinal parasite screening in wellness and sick-pet care.
IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles
07:00am, Tuesday, 19'th May 2026
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX integrates SDMA into most common Catalyst chemistry profiles, enabling earlier detection of kidney disease through routine in‑clinic testing.
The Biology Came First.
09:00am, Monday, 18'th May 2026
MindWalk Holdings Corp. (NASDAQ: HYFT) today released a systematic report identifying over 20 discovery-originated drug candidates with documented origins in a
IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day
04:34pm, Thursday, 14'th May 2026
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, President and Chief Executive Officer, wil
IDEXX Laboratories Inc (IDXX) Shares Fall 5.0% -- What GF Score of 99 Tells Investors
07:52pm, Monday, 11'th May 2026
On May 11, 2026, IDEXX Laboratories Inc (IDXX) shares fell 5.0% to a current price of $532.00. This decline comes amid a challenging performance period for the
IDEXX Laboratories, Inc. (IDXX) Q1 2026 Earnings Call Transcript
02:11pm, Tuesday, 05'th May 2026
IDEXX Laboratories, Inc. (IDXX) Q1 2026 Earnings Call Transcript
IDEXX Stock Up on Q1 Earnings & Revenue Beat, Margins Rise, '26 View Up
11:31am, Tuesday, 05'th May 2026
IDXX rides strong on Q1 beats with rising margins; lifts 2026 outlook as diagnostics growth and innovation momentum fuel performance.
Idexx (IDXX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
10:30am, Tuesday, 05'th May 2026
The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Idexx Laboratories Raises Guidance On Higher Clinical Visits, Diagnostic Frequency
10:20am, Tuesday, 05'th May 2026
Idexx Laboratories Inc (NASDAQ:IDXX) shares are up on Tuesday as the company recently announced strong first-quarter results, showcasing a 14% revenue growth.
